医学研究：试验的不可预测性产生可预测的治疗效果。
Medical research: Trial unpredictability yields predictable therapy gains.
机构信息
Department of Internal Medicine, University of South Florida, Tampa, Florida, USA.
出版信息
Nature. 2013 Aug 22;500(7463):395-6. doi: 10.1038/500395a.
Abstract
In decades of clinical-trial data, new treatments are better than standard ones just over half the time. That's as it should be, say and colleagues.
摘要
在几十年的临床试验数据中，新疗法的疗效超过标准疗法的情况仅超过一半。研究人员表示，情况本该如此。
相似文献
1
Medical research: Trial unpredictability yields predictable therapy gains.医学研究：试验的不可预测性产生可预测的治疗效果。
Nature. 2013 Aug 22;500(7463):395-6. doi: 10.1038/500395a.
2
Random treatment assignment using mathematical equipoise for comparative effectiveness trials.采用数学均衡随机分组进行比较有效性试验。
Clin Transl Sci. 2011 Feb;4(1):10-6. doi: 10.1111/j.1752-8062.2010.00253.x.
3
Equipoise and the dilemma of randomized clinical trials.equipoise与随机临床试验的困境
N Engl J Med. 2011 Feb 3;364(5):476-80. doi: 10.1056/NEJMsb1011301.
4
The search for improved antidepressant strategies: is bigger better?寻找改进的抗抑郁策略：越大越好吗？
Am J Psychiatry. 2011 Jul;168(7):664-6. doi: 10.1176/appi.ajp.2011.11030510.
5
Patient-centred equipoise and the ethics of randomised controlled trials.以患者为中心的 equipoise 与随机对照试验的伦理学
Monash Bioeth Rev. 2002 Apr;21(2):S55-67. doi: 10.1007/BF03351269.
6
Different meanings of equipoise and the four quadrants of uncertainty.
J Clin Epidemiol. 2020 Nov;127:248-249. doi: 10.1016/j.jclinepi.2020.07.010. Epub 2020 Jul 17.
7
[Real-world data and clinical research: The complement data from randomized trials].
Presse Med. 2015 Jun;44(6 Pt 1):586-9. doi: 10.1016/j.lpm.2015.02.005. Epub 2015 May 6.
8
Evaluation of Lowering the P Value Threshold for Statistical Significance From .05 to .005 in Previously Published Randomized Clinical Trials in Major Medical Journals.评估主要医学期刊中先前发表的随机临床试验将统计显著性的 P 值阈值从 0.05 降低至 0.005 的效果。
JAMA. 2018 Nov 6;320(17):1813-1815. doi: 10.1001/jama.2018.12288.
9
Many randomized clinical trials may not be justified: a cross-sectional analysis of the ethics and science of randomized clinical trials.许多随机临床试验可能没有道理：对随机临床试验的伦理和科学进行的横断面分析。
J Clin Epidemiol. 2018 May;97:20-25. doi: 10.1016/j.jclinepi.2017.12.027. Epub 2018 Jan 3.
10
The Question of Clinical Equipoise and Patients' Best Interests.临床 equipoise 与患者最佳利益问题
AMA J Ethics. 2015 Dec 1;17(12):1108-15. doi: 10.1001/journalofethics.2015.17.12.ecas1-1512.
引用本文的文献
1
The death of a neurotrauma trial lessons learned from the prematurely halted randomized evaluation of surgery in elderly with traumatic acute subdural hematoma (RESET-ASDH) trial.一项神经创伤试验的死亡教训：从针对老年创伤性急性硬膜下血肿患者手术的随机评估（RESET-ASDH）试验过早中止中吸取的经验教训
Brain Spine. 2024 Jul 18;4:102903. doi: 10.1016/j.bas.2024.102903. eCollection 2024.
2
Accuracy of Event Rate and Effect Size Estimation in Major Cardiovascular Trials: A Systematic Review.主要心血管试验中事件发生率和效应量估计的准确性：系统评价。
JAMA Netw Open. 2024 Apr 1;7(4):e248818. doi: 10.1001/jamanetworkopen.2024.8818.
3
Response to Letter from Wong on determining the target difference in sample size calculations for randomised controlled trials.对Wong关于确定随机对照试验样本量计算中目标差异的来信的回复。
Trials. 2024 Mar 2;25(1):161. doi: 10.1186/s13063-024-08023-x.
4
Large numbers of patients are needed to obtain additional approvals for new cancer drugs: A retrospective cohort study.需要大量患者来获得新癌症药物的额外批准：一项回顾性队列研究。
Sci Rep. 2023 Sep 26;13(1):16138. doi: 10.1038/s41598-023-42213-y.
5
Uptake of the multi-arm multi-stage (MAMS) adaptive platform approach: a trial-registry review of late-phase randomised clinical trials.多臂多阶段（MAMS）自适应平台方法的应用：晚期随机临床试验的试验注册回顾。
BMJ Open. 2022 Mar 10;12(3):e055615. doi: 10.1136/bmjopen-2021-055615.
6
Identification of threshold for large (dramatic) effects that would obviate randomized trials is not possible.确定可以避免随机试验的大（显著）效果的阈值是不可能的。
J Clin Epidemiol. 2022 May;145:101-111. doi: 10.1016/j.jclinepi.2022.01.016. Epub 2022 Jan 25.
7
The statistical properties of RCTs and a proposal for shrinkage.随机对照试验的统计特性及收缩估计方法的提出
Stat Med. 2021 Nov 30;40(27):6107-6117. doi: 10.1002/sim.9173. Epub 2021 Aug 23.
8
Realising the full potential of data-enabled trials in the UK: a call for action.挖掘英国数据驱动型试验的全部潜力：行动呼吁。
BMJ Open. 2021 Jun 16;11(6):e043906. doi: 10.1136/bmjopen-2020-043906.
9
Unperceived similarities between clinical trials and quantum physics.临床试验与量子物理学之间未被察觉的相似之处。
Br J Clin Pharmacol. 2020 Feb;86(2):192-193. doi: 10.1111/bcp.14126. Epub 2020 Jan 14.
10
US Food and Drug Administration Approvals of Drugs and Devices Based on Nonrandomized Clinical Trials: A Systematic Review and Meta-analysis.美国食品和药物管理局基于非随机临床试验批准的药物和设备：系统评价和荟萃分析。
JAMA Netw Open. 2019 Sep 4;2(9):e1911111. doi: 10.1001/jamanetworkopen.2019.11111.
本文引用的文献
1
Treatment success in cancer: industry compared to publicly sponsored randomized controlled trials.癌症治疗的成功：行业与公共资助的随机对照试验比较。
PLoS One. 2013;8(3):e58711. doi: 10.1371/journal.pone.0058711. Epub 2013 Mar 21.
2
New treatments compared to established treatments in randomized trials.随机试验中新型治疗方法与既定治疗方法的比较。
Cochrane Database Syst Rev. 2012 Oct 17;10(10):MR000024. doi: 10.1002/14651858.MR000024.pub3.
3
Avoidable waste in the production and reporting of research evidence.研究证据生产与报告中的可避免浪费。
Lancet. 2009 Jul 4;374(9683):86-9. doi: 10.1016/S0140-6736(09)60329-9. Epub 2009 Jun 12.
4
Strong Inference: Certain systematic methods of scientific thinking may produce much more rapid progress than others.强推理：某些系统的科学思维方法可能比其他方法产生更快的进展。
Science. 1964 Oct 16;146(3642):347-53. doi: 10.1126/science.146.3642.347.
5
Articulating and responding to uncertainties in clinical research.阐明并应对临床研究中的不确定性。
J Med Philos. 2007 Mar-Apr;32(2):79-98. doi: 10.1080/03605310701255719.
6
When are randomised trials unnecessary? Picking signal from noise.随机试验何时不必要？从噪声中挑选信号。
BMJ. 2007 Feb 17;334(7589):349-51. doi: 10.1136/bmj.39070.527986.68.
7
What is the prior probability of a proposed new treatment being superior to established treatments?一种新提出的治疗方法优于现有治疗方法的先验概率是多少？
BMJ. 1997 Jan 4;314(7073):74-5. doi: 10.1136/bmj.314.7073.74a.
8
Sorting out the doctor's bag.
Control Clin Trials. 1980 Dec;1(3):263-7. doi: 10.1016/0197-2456(80)90006-9.
Zotero 插件